Diana Girnita, MD, PhD, founder and CEO of Rheumatologist OnCall, has a thriving YouTube channel with nearly 100K subscribers and over 500 videos to date. She...
Our ophthalmology month in review for June 2024 focuses on updates to the pipeline, a look at the impact of vision problems on public health in...
Multiple myeloma is one of the most common forms of cancer of the immune cells in the bone marrow. It is considered incurable. Even when patients...
Credit: Unsplash/Bady Abbas A recent investigation in JAMA Ophthalmology evaluated the frequency of topical antibiotic treatment and its association with healthcare use among children and adolescents...
Researchers from the University of Missouri School of Medicine found that a targeted gene therapy may make acute myeloid leukemia (AML) more sensitive to chemotherapy, while...
Jennifer Goldman, RPh, PharmDCredit: Massachusetts College of Pharmacy Since the turn of the century, diabetes management has seen, and is still in the midst of, dramatic...
Richard Pratley, MDCredit: Advent Health Diabetes Institute Exactly 1 month after its original presentation at the 61st European Renal Association Congress, the FLOW trial and semaglutide...
Credit: Adobe Stock/eddows Treatment with romosozumab or denosumab among patients with either primary osteoporosis or rheumatoid arthritis (RA) complicated with osteoporosis (RA-OP) demonstrated clinical efficacy over...
On the opening day of the 84th American Diabetes Association Scientific Sessions, the ADA ushered in a new era for their organization with the announcement of...
Despite medical cannabis in the US dating back more than 3 decades, the legalization movement in the last decade means millions and millions of US adults...
1. Dual antiplatelet therapy with ticagrelor and asprin led to a significantly lower risk of major adverse cardiovascular events over 5 years compared to ticagrelor or...
Todd Hagobian, PhD Credit: Cal Poly Findings from a recent study suggest limiting exposure to bisphenol A (BPA) may help reduce the risk of type 2...